Bumbershoot had over 10+ companies drop more than -15% in Dec. 2024. So, why does Bumbershoot actually believe 2024 was a ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Join Meeple Mountain to celebrate Dr Reiner Knizia’s 40 year board game career by journeying through his game portfolio, from ...
Post readers dive into transgender issues in sports, science and more.
We're debating over whether to put all of that cash into the S&P 500 or buy individual stocks. We have chosen two stocks that have done well over the past five years: Chevron, with a 22% annual return ...
Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
This conclusion is supported by our analysis comparing Google's present valuation with its operating performance in recent ...
The biologist shows a video on his cellphone of humans after taking this pill. The chemist notes that he himself has taken ...
Seize the opportunity to invest in Alphabet stock at a 20% discount. Discover growth insights in search, cloud, and media ...